Jeong Jong Hwan, Kim Ho Cheol, Lee Jae Seung, Choi Chang-Min, Ji Wonjun
Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Division of Pulmonology and Allergy, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, South Korea.
J Thorac Dis. 2025 Mar 31;17(3):1259-1267. doi: 10.21037/jtd-24-924. Epub 2025 Mar 12.
Transthoracic needle biopsy (TTNB) is a widely used technique for assessing parenchymal lung diseases. However, pneumothorax often occurs after TTNB and may sometimes require chest tube drainage. We aimed to evaluate the efficacy and safety of simple needle aspiration for treating moderate to severe non-tension pneumothorax following TTNB.
This prospective, single-center pilot study conducted between May and November 2021. Participants with non-tension pneumothorax measuring >25% in size on radiography after TTNB were included. Simple needle aspirations were performed through the second intercostal space on the midclavicular line using a 16-gauge angio-catheter. Changes in the size of the pneumothorax were assessed using chest radiographs at 1 and 12 h postprocedure.
Seven patients with moderate to severe pneumothorax after TTNB were included. Needle aspirations were successful in all patients without complications. Pneumothoraces improved in five patients after needle aspiration, eliminating the need for chest tube drainage. However, in two patients, pneumothorax of a similar size persisted after needle aspiration and was subsequently resolved with chest tube drainage. The mean duration of hospital stay for the patients with successful needle aspiration was shorter (3.8 d) compared to those requiring chest tube drainage after failed needle aspiration (8 d). Two patients who underwent chest tube drainage reported pain [Numeric Rating Scale (NRS) 4] and received analgesic drugs, while no pain (NRS 0) was reported after needle aspiration.
Needle aspiration is a safe and effective procedure for the treatment of moderate to severe non-tension pneumothorax following TTNB. It may reduce the need for chest tube insertion, shorten hospitalization duration, and decrease procedure-related pain and analgesic use.
经胸针吸活检(TTNB)是评估实质性肺部疾病广泛使用的技术。然而,TTNB后气胸常发生,有时可能需要胸腔闭式引流。我们旨在评估单纯针吸治疗TTNB后中度至重度非张力性气胸的有效性和安全性。
这项前瞻性单中心试点研究于2021年5月至11月进行。纳入TTNB后胸部X线显示气胸大小>25%的非张力性气胸患者。使用16G血管导管在锁骨中线第二肋间进行单纯针吸。术后1小时和12小时通过胸部X线评估气胸大小的变化。
纳入7例TTNB后中度至重度气胸患者。所有患者针吸均成功,无并发症。5例患者针吸后气胸改善,无需胸腔闭式引流。然而,2例患者针吸后气胸大小相似,随后通过胸腔闭式引流得以缓解。针吸成功患者的平均住院时间(3.8天)比针吸失败后需要胸腔闭式引流的患者(8天)短。2例接受胸腔闭式引流的患者报告疼痛(数字评定量表[NRS]4分)并接受了镇痛药,而针吸后未报告疼痛(NRS 0分)。
针吸是治疗TTNB后中度至重度非张力性气胸的一种安全有效的方法。它可能减少胸腔闭式引流的需要,缩短住院时间,并减少与操作相关的疼痛和镇痛药的使用。